Feedback unseren Kunden
Ihr Warenkorb
€0.00 (0 artikel)
Search:
Perform search
Produktkategorien

Generisches Tolterodine - Detrol, Detrol La

News
Suche nach Anfangsbuchstaben:ABCDEFGHIJKLMNOPQRSTUVWXYZ
Detrol
Generisches Detrol hilft bei überaktiver Blase im Zusammenhang mit Harndrang, Kontrollverlust etc.
€1.08
Detrol La
Generic Detrol LA hilft bei überaktiver Blase im Zusammenhang mit Harndrang, Kontrollverlust etc.
€2.90

Tag: tolterodine kaufen in tschechien, detrol in europa kaufen, tolterodine jetzt kaufen, detrol ohne rezept, tolterodine kaufen ohne rezept, detrol generic günstig kaufen, tolterodine bestellen paypal, detrol kaufen günstig, tolterodine preisliste, detrol deutschland rezeptfrei.

Soziale Lesezeichen
Choose your language:



Geld zurückGarantie
Sichereinkaufen

Unsere Rechnungsführung ist zertifiziert durch:

Secure shopping certificates

Special Offer!

  • This RSS feed URL is deprecated

    This RSS feed URL is deprecated, please update.

  • Tolterodine hydrobromide (CAS 837376-36-0) Market by Manufacturers and Sales 2017 to 2022 - BelAir Daily (press release)

    Business AnalyticsTolterodine hydrobromide (CAS 837376-36-0) Market by Manufacturers and Sales 2017 to 2022BelAir Daily (press release)'Tolterodine hydrobromide (CAS 837376-36-0) Market by Manufacturers and Sales 2017 to 2022' is a professional and in-depth study on the current state of the global Tolterodine hydrobromide (CAS 837376-36-0) Market with a focus on the major countries .

  • Overactive Bladder Drug Market 2018: Industry Demand, Insight & Forecast By 2023 - Pharmaceuticals News

    Overactive Bladder Drug Market 2018: Industry Demand, Insight & Forecast By 2023Pharmaceuticals NewsOn the basis of product, this report displays the production, revenue, price, Overactive Bladder Drug market share and growth rate of each type, primarily split into: Anticholinergics, Solifenacin, Oxybutynin, Darifenacin, Fesoterodine, Tolterodine .

  • Overactive Bladder Therapeutics Market to Record Sturdy Growth by ... - Pharmaceuticals News

    Overactive Bladder Therapeutics Market to Record Sturdy Growth by .

  • Urovant Sciences Initiates Phase 3 Clinical Program for Vibegron in ... - PR Newswire (press release)

    FierceBiotechUrovant Sciences Initiates Phase 3 Clinical Program for Vibegron in .

    Copyright © www.ohnerezeptfreikauf.com is an affiliate marketing website. All rights reserved.